Net profit of Ipca Laboratories rose 13.81% to Rs 67.82 crore in the quarter ended March 2025 as against Rs 59.59 crore during the previous quarter ended March 2024. Sales rose 10.51% to Rs 2246.69 crore in the quarter ended March 2025 as against Rs 2033.03 crore during the previous quarter ended March 2024.
For the full year,net profit rose 34.77% to Rs 737.68 crore in the year ended March 2025 as against Rs 547.35 crore during the previous year ended March 2024. Sales rose 16.02% to Rs 8939.59 crore in the year ended March 2025 as against Rs 7705.04 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 2246.69 | 2033.03 | 11 | 8939.59 | 7705.04 | 16 |
| OPM % | 19.09 | 15.83 | - | 19.31 | 17.15 | - |
| PBDT | 433.17 | 311.45 | 39 | 1734.01 | 1307.66 | 33 |
| PBT | 333.05 | 213.32 | 56 | 1336.19 | 950.42 | 41 |
| NP | 67.82 | 59.59 | 14 | 737.68 | 547.35 | 35 |